A NEW POINT MUTATION IN A HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE-DEFICIENT PATIENT
Citation
Ri. Hidalgolaos et al., A NEW POINT MUTATION IN A HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE-DEFICIENT PATIENT, Pediatric nephrology, 11(5), 1997, pp. 645-648
Categorie Soggetti
Pediatrics,"Urology & Nephrology
Journal title
Pediatric nephrology
SICI code
0931-041X(1997)11:5<645:ANPMIA>2.0.ZU;2-H
Abstract
A 12-year-old boy was referred because of abdominal pain, gross hematu
ria, and passage of stones. Further evaluation showed growth delay, lo
w average range of intellectual functioning, and a speech articulation
dis order. No signs of self-mutilation or self-injurious behavior wer
e present. He had hyperuricemia, hyperuricosuria, uric acid crystallur
ia, uric acid calculi, macrocytosis, megaloblastic bone marrow changes
, and mild anemia. Hypoxanthine phosphoribosyltransferase (HPRT) enzym
e activity was reduced to approximately 26% of normal. Polymerase chai
n reaction-single strand conformational polymorphism analysis of the H
PRT gene in DNA isolated from the patient's blood lymphocytes revealed
a single nucleotide substitution at codon 200 in exon 8. The base cha
nge was a guanine to cytosine transversion, resulting in the conservat
ive amino acid substitution of threonine in place of arginine. To our
knowledge, this mutation has not previously been reported.